MedPath

Effect of Non-surgical Periodontal Treatment on Cardiovascular Risk Markers

Completed
Conditions
Coronary Heart Disease
Periodontitis
Interventions
Procedure: non-surgical periodontal treatment
Registration Number
NCT04305171
Lead Sponsor
Mahidol University
Brief Summary

The research question was to investigate whether non-surgical periodontal therapy could reduce cardiovascular risk markers in Coronary heart disease (CHD) patients.

Detailed Description

CHD patients or non-CHD with or without periodontitis were included. They were provided with non-surgical periodontal therapy (NSPT). Periodontal parameters and cardiovascular risk markers were measured at baseline and 3 months and 6 months after NSPT.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
28
Inclusion Criteria
  • non-CHD or CHD (at least 50% diameter stenosis in at least one coronary artery and clinically stable with absence of any potentially confounding inflammatory conditions for at least 6 months)
  • had at least 14 natural teeth excluding third molars
Exclusion Criteria
  • received anticoagulant drugs
  • had chronic conditions (e.g. diabetes mellitus, rheumatoid arthritis, malignancy, autoimmune disease) or acute conditions (e.g. trauma, surgery) or medications known to affect systemic inflammatory markers (e.g. antibiotics, immunosuppressive, contraceptives) within 3 months
  • pregnancy or lactation
  • presence or history of other infections
  • periodontal treatment within 6 months
  • tooth extractions within 2 months prior to the study.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
non-coronary heart disease patients without periodontitisnon-surgical periodontal treatmentNon-periodontitis classified as having PD ≤ 3 mm.
non-coronary heart disease patients with periodontitisnon-surgical periodontal treatmentPeriodontitis classified as havingbleeding on probing (BOP), pocket depth (PD) \> 4 mm, clinical attachment level (CAL) ≥ 5 mm and radiographic evidence of bone loss were presented at the same site of at least 4 teeth.
coronary heart disease patients with periodontitisnon-surgical periodontal treatmentCoronary heart disease patients confirmed through coronary angiography as having at least 50% diameter stenosis in at least one coronary artery and clinically stable with the absence of any potentially confounding inflammatory conditions for at least 6 months. Periodontitis classified as havingbleeding on probing (BOP), pocket depth (PD) \> 4 mm, clinical attachment level (CAL) ≥ 5 mm and radiographic evidence of bone loss were presented at the same site of at least 4 teeth.
coronary heart disease patients without periodontitisHDnon-surgical periodontal treatmentCoronary heart disease patients confirmed through coronary angiography as having at least 50% diameter stenosis in at least one coronary artery and clinically stable with the absence of any potentially confounding inflammatory conditions for at least 6 months. Non-periodontitis classified as having PD ≤ 3 mm.
Primary Outcome Measures
NameTimeMethod
change in fibrinogen level between baseline and 3 months after non-surgical periodontal treatment3 months after non-surgical periodontal treatment

change in plasma fibrinogen level (pg/mL)

change in C-reactive protein between baseline and 3 months after non-surgical periodontal treatment3 months after non-surgical periodontal treatment

change in C-reactive protein level (mg/L)

change in fibrinogen level between baseline and 6 months after non-surgical periodontal treatment6 months after non-surgical periodontal treatment

change in plasma fibrinogen level (pg/mL)

change in C-reactive protein between baseline and 6 months after non-surgical periodontal treatment6 months after non-surgical periodontal treatment

change in C-reactive protein level (mg/L)

change in activator inhibitor 1 between baseline and 3 months after non-surgical periodontal treatment3 months after non-surgical periodontal treatment

change in activator inhibitor 1 level (pg/mL)

change in activator inhibitor 1 between baseline and 6 months after non-surgical periodontal treatment6 months after non-surgical periodontal treatment

change in activator inhibitor 1 level (pg/mL)

Secondary Outcome Measures
NameTimeMethod
change of bleeding on probing between baseline and 6 months after non-surgical periodontal treatment6 months after non-surgical periodontal treatment

percetage of sites with bleeding on probing

change of pocket depth between baseline and 6 months after non-surgical periodontal treatment6 months after non-surgical periodontal treatment

Depth of periodontal pocket in millimeters

change of bleeding on probing between baseline and 3 months after non-surgical periodontal treatment3 months after non-surgical periodontal treatment

percetage of sites with bleeding on probing

change of clinical attachment level between baseline and 6 months after non-surgical periodontal treatment6 months after non-surgical periodontal treatment

Level of clinical attachment in millimeters

change of pocket depth between baseline and 3 months after non-surgical periodontal treatment3 months after non-surgical periodontal treatment

Depth of periodontal pocket in millimeters

change of clinical attachment level between baseline and 3 months after non-surgical periodontal treatment3 months after non-surgical periodontal treatment

Level of clinical attachment in millimeters

Trial Locations

Locations (3)

Department of Medicine, Rajavithi Hospital

🇹🇭

Ratchathewi, Bangkok, Thailand

Mahidol University Faculty of Dentistry

🇹🇭

Ratchathewi, Bangkok, Thailand

Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University

🇹🇭

Ratchathewi, Bangkok, Thailand

© Copyright 2025. All Rights Reserved by MedPath